MARKET

VXRT

VXRT

Vaxart Inc
NASDAQ
0.3787
-0.0364
-8.77%
After Hours: 0.3900 +0.0113 +2.98% 19:58 05/06 EDT
OPEN
0.4200
PREV CLOSE
0.4151
HIGH
0.4200
LOW
0.3701
VOLUME
1.67M
TURNOVER
--
52 WEEK HIGH
1.070
52 WEEK LOW
0.2850
MARKET CAP
86.42M
P/E (TTM)
-1.1434
1D
5D
1M
3M
1Y
5Y
1D
Vaxart Resumes COVID-19 Vaccine Trial After Government Lift
TipRanks · 1d ago
Vaxart CEO issues letter to shareholders
TipRanks · 1d ago
Press Release: Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress
Dow Jones · 1d ago
Press Release: Vaxart CEO Issues Letter to -2-
Dow Jones · 1d ago
Weekly Report: what happened at VXRT last week (0428-0502)?
Weekly Report · 1d ago
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
Barchart · 5d ago
Vaxart Advances Norovirus Vaccine Program With Completed Phase 1 Enrollment
NASDAQ · 6d ago
Vaxart completes enrollment in Phase 1 trial of Norovirus pill candidate
TipRanks · 6d ago
More
About VXRT
More
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.
Recently
Symbol
Price
%Change

Webull offers Vaxart Inc stock information, including NASDAQ: VXRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VXRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VXRT stock methods without spending real money on the virtual paper trading platform.